RT @drdavidliew: Dazodalibep is the next CD40L inhibitor being tested in Sjogrenâs - we need better therapies genuinel
Tweet Content
Dazodalibep is the next CD40L inhibitor being tested in Sjogren’s - we need better therapies genuinely reducing symptom burden. Nice phase 2 data analyses so far of subjective measures, and plenty will be happy if we see this kind of result in phase 3
LB0003 #EULAR2023 @RheumNow https://t.co/HYcXEzswAg
Show on Archive Page
On
Display in Search Results
On
PDQ
Off